Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinsons disease and cardiac hypertrophy[1][2][3][4].
Molecular Weight:
212.23
Purity:
99.94
CAS Number:
[68291-97-4]
Formula:
C8H8N2O3S
Target:
Apoptosis,Carbonic Anhydrase
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
